The mitochondrial-derived peptide MOTS-c suppresses ferroptosis and alleviates acute lung injury induced by myocardial ischemia reperfusion via PPARγ signaling pathway

Eur J Pharmacol. 2023 Aug 15:953:175835. doi: 10.1016/j.ejphar.2023.175835. Epub 2023 Jun 7.

Abstract

Acute lung injury (ALI) is a life-threatening complication of cardiac surgery that has a high rate of morbidity and mortality. Epithelial ferroptosis is believed to be involved in the pathogenesis of ALI. MOTS-c has been reported to play a role in regulating inflammation and sepsis-associated ALI. The purpose of this study is to observe the effect of MOTS-c on myocardial ischemia reperfusion (MIR)-induced ALI and ferroptosis. In humans, we used ELISA kits to investigate MOTS-c and malondialdehyde (MDA) levels in patients undergoing off-pump coronary artery bypass grafting (CABG). In vivo, we pretreated Sprague-Dawley rats with MOTS-c, Ferrostatin-1 and Fe-citrate(Ⅲ). We conducted Hematoxylin and Eosin (H&E) staining and detection of ferroptosis-related genes in MIR-induced ALI rats. In vitro, we evaluated the effect of MOTS-c on hypoxia regeneration (HR)-induced mouse lung epithelial-12 (MLE-12) ferroptosis and analyzed the expression of PPARγ through western blotting. We found that circulating MOTS-c levels were decreased in postoperative ALI patients after off-pump CABG, and that ferroptosis contributed to ALI induced by MIR in rats. MOTS-c suppressed ferroptosis and alleviated ALI induced by MIR, and the protective effect of MOTS-c- was dependent on PPARγ signaling pathway. Additionally, HR promoted ferroptosis in MLE-12 cells, and MOTS-c inhibited ferroptosis against HR through the PPARγ signaling pathway. These findings highlight the therapeutic potential of MOTS-c for improving postoperative ALI induced by cardiac surgery.

Keywords: Acute lung injury; Ferroptosis; MOTS-c; Myocardial ischemia reperfusion; Peroxisome proliferator-activated receptor γ.

MeSH terms

  • Acute Lung Injury* / chemically induced
  • Acute Lung Injury* / etiology
  • Animals
  • Coronary Artery Disease* / complications
  • Ferroptosis*
  • Humans
  • Ischemia / complications
  • Mice
  • Myocardial Reperfusion Injury* / complications
  • Myocardial Reperfusion Injury* / drug therapy
  • Myocardial Reperfusion Injury* / metabolism
  • PPAR gamma / metabolism
  • Peptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury* / complications
  • Signal Transduction
  • Transcription Factors

Substances

  • PPAR gamma
  • Transcription Factors
  • Peptides